COVID-19 Real-world Data Infrastructure (CRWDi) is a company within the Healthcare Research category. The COVID-19 Real-world Data Infrastructure (CRWDi) was an initiative designed to develop a large-scale real-world data (RWD) infrastructure. It utilized Privacy Preserving Record Linkage (PPRL) to integrate comprehensive longitudinal data from various sources to enable research on SARS-CoV-2 infection and immunization, with a particular focus on immunocompromised patient populations, including those with cancer, rheumatologic diseases, or organ/stem cell transplants. The initiative is no longer accepting new data requests but remains active for current users until April 2026.
COVID-19 Real-world Data Infrastructure (CRWDi) was founded in In response to the COVID-19 pandemic (likely 2020-2021). and is headquartered in Bethesda, Maryland, USA (associated with National Institutes of Health)..
COVID-19 Real-world Data Infrastructure (CRWDi) is rated Emerging on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for COVID-19 Real-world Data Infrastructure (CRWDi) is Moderate. Significant factual deltas detected.
AI models classify COVID-19 Real-world Data Infrastructure (CRWDi) as a Challenger. AI names competitors first.
COVID-19 Real-world Data Infrastructure (CRWDi) appeared in 5 of 5 sampled buyer-intent queries (100%). Discoverability is high for specific queries related to 'CRWDi' or 'COVID-19 Real-world Data Infrastructure' given the official source. However, a general search for 'Real World Data Collection' might not directly lead to this specific, time-limited initiative, as the name is broad and the project is winding down, potentially reducing its prominence in generic RWD searches over time.
CRWDi is perceived as a significant government-led (NIH/NCI) initiative that successfully established a critical real-world data infrastructure to address pandemic-related research gaps, specifically regarding COVID-19 outcomes and vaccine efficacy in vulnerable, immunocompromised populations. It is recognized for its comprehensive data linkage using privacy-preserving technologies and its focus on detailed cancer patient data. However, its operational status as no longer accepting new data requests and its planned duration until April 2026 are key aspects of its current perception. Key gap: None identified. The provided text is consistent and self-explanatory, outlining the initiative's purpose, methods, and current operational status.
Of 5 key facts verified about COVID-19 Real-world Data Infrastructure (CRWDi), 4 are well-documented (likely accurate across AI models), 0 have limited sourcing, and 1 are retrieval-dependent and may be inaccurate without live search.
The primary vulnerability is that the CRWDi initiative is in a sunset phase, no longer accepting new data requests and scheduled to cease operations for existing users by April 2026. This significantly limits its future utility and accessibility for new research projects, making it a temporary rather than a continuously evolving resource.
Buyers turn to COVID-19 Real-world Data Infrastructure (CRWDi) for Manual Data Collection and Linkage: Attempting to manually collect, standardize, and link individual patient records across claims, pharmacies, labs, and cancer registries at a national scale for spec, Contract Research Organization (CRO) / Data Consultancy: Hiring a CRO or specialized data consultancy could provide expertise in data aggregation and analysis. However, replicating CRWDi's established, Lack of Centralized COVID-19 RWD for Immunocompromised: Without CRWDi, researchers would lack a critical, centralized, and ethically linked real-world dataset focused on COVID-19 outcomes and vaccine , among 3 documented problem areas.
Buyers evaluating COVID-19 Real-world Data Infrastructure (CRWDi) typically ask AI models about "CRWDi", "COVID-19 Real-world Data Infrastructure", "SEER COVID-19 data immunocompromised", and 3 similar queries.
COVID-19 Real-world Data Infrastructure (CRWDi)'s core products are A secure, linked longitudinal real-world data (RWD) infrastructure containing medical claims, pharmacy claims, lab results (SARS-CoV-2 diagnostic and serologic), and detailed cancer patient data (from SEER registries) for research..
COVID-19 Real-world Data Infrastructure (CRWDi) uses Not explicitly detailed, but as a government-funded NIH/NCI initiative, access for approved researchers is likely managed through an application process rather than a commercial pricing structure..
COVID-19 Real-world Data Infrastructure (CRWDi) serves Researchers, epidemiologists, public health organizations, and policymakers focused on understanding COVID-19 infection, immunization, and treatment outcomes, particularly in immunocompromised patient populations (cancer, rheumatologic diseases, transplant recipients)..
COVID-19 Real-world Data Infrastructure (CRWDi) Its unique combination of large-scale, linked, longitudinal real-world data from diverse sources (claims, labs, SEER cancer data), focused specifically on COVID-19 in high-risk immunocompromised populations, and employing Privacy Preserving Record Linkage (PPRL) to ensure data privacy while enabling comprehensive research.
Brand Authority Index (BAI) tier: Emerging (exact score locked for unclaimed brands)
Archetype: Challenger
https://optimly.ai/brand/real-world-data-collection
Last analyzed: July 19, 2026
Founded: 2020
Headquarters: Bethesda, Maryland, USA (National Institutes of Health)
This profile is part of the Optimly Brand Trust Registry — a verified index of 60,000+ brand profiles that AI models read from when answering buyer-intent questions about brands and categories. Optimly identifies which third-party sources AI cites about each brand, prepares structured brand information for those sources, and measures whether AI representation improves.
If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile